singleron-logo_800px.png
Singleron to present novel single cell sequencing solutions for blood cancer research at the 64th ASH Annual Meeting & Exposition
14 nov. 2022 03h00 HE | Singleron Biotechnologies GmbH
COLOGNE, Germany, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions for precision...
singleron-logo_800px.png
Singleron opens a new state-of-the-art laboratory to showcase the latest single cell sequencing technology
07 nov. 2022 03h00 HE | Singleron Biotechnologies Pte. Ltd.
COLOGNE, Germany, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Singleron Biotechnologies, a leader in single cell multi-omics analysis, is happy to announce the opening of their brand-new laboratories in...
singleron-logo_800px.png
First commercial kit to quantify protein modification in single cells launched by Singleron Biotechnologies
03 nov. 2022 10h00 HE | Singleron Biotechnologies Pte. Ltd.
COLOGNE, Germany, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Singleron Biotechnologies, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions, announces the...
Logos for Singleron, Maleth II and the University of Malta.
Singleron supports Project Maleth’s second mission MALETH II by analyzing biological samples sent to space
14 juil. 2022 23h00 HE | Singleron Biotechnologies Pte. Ltd.
COLOGNE, Germany, July 14, 2022 (GLOBE NEWSWIRE) -- Maleth Program is the first space bioscience project led by Professor Joseph Borg of the University of Malta. The second mission under the Maleth...
Proteona Lab Opening
Proteona opens new laboratory in Singapore
10 mai 2022 21h01 HE | Proteona
SINGAPORE, May 10, 2022 (GLOBE NEWSWIRE) -- Proteona Pte. Ltd., a subsidiary of Singleron Biotechnologies, and a leader in single-cell multi-omics analysis, today announced the opening of a new...
ash2021
Proteona announces multiple ASH presentations highlighting novel gene signatures in hematological cancers identified using advanced single-cell biomarker discovery platform
08 déc. 2021 06h38 HE | Proteona
SINGAPORE, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Proteona, a single-cell precision medicine company, today announced that three abstracts from the company and its collaborators have been accepted for...